Edmund F. La Gamma, M.D. '76, is the chief of the Division of Newborn Medicine and is the director of the 49-bed Regional Neonatal Center of the Maria Fareri Children’s Hospital. His division has the third largest fellowship program in America with a 98% board pass rate since 1999. Dr. La Gamma was an elected member of the Council of the Society for Pediatric Research; is the past President of the New York Perinatal Society; a former Secretary of the Easter SPR as well as elected their “Mentor of the Year 2015” and is the recipient of grants from the NIH, NSF, March of Dimes, Dysautonomia Foundation, American Heart Association and industry. Dr. La Gamma has been on various regional and national “Best Doctors” lists for more than 20 years. He has served on multiple NIH Study Sections. He holds two patents on clinically relevant research and is a consultant to industry. In 2023, he received the NYMC School of Medicine Dean's Faculty Award for Outstanding Achievement.

Clinical Specialty

• Neonatology

Education

• M.D. '76, New York Medical College
• Internship, Internal Medicine, New York and Presbyterian Hospital-Cornell Campus
• Residency, Pediatrics, New York Hospital-Cornell Medical Center
• Fellowship, Neonatal-Perinatal Medicine, New York Hospital-Cornell Medical Center

Honors and Awards

• 2023 NYMC School of Medicine Dean's Faculty Award for Outstanding Achievement

Research

Dr. La Gamma has published over 145 peer-reviewed reports on basic science and clinical research and authored over 25 invited chapters on various aspects of neonatal disease, nutrition, infection and development of the nervous system.

Publications

• Jethe JV, Shen YY, LaGamma EF, et. al. "Noninvasive optical monitoring of cerebral hemodynamics in a preclinical model of neonatal intraventricular hemorrhage." bioRxiv : the preprint server for biology, (), (2024) . pii: 2024.10.16.618768. doi: 10.1101/2024.10.16.618768
• Finkel DA, Malfa A, Liao Y, et. al. "Early Postnatal Expression of Tgfβ-1 and Fgf-2 Correlates With Regenerative Functions of Unrestricted Somatic Stem Cell Infusion After Rabbit GMH-IVH." Stem cells translational medicine, 12(12), (2023) 811-824. doi: 10.1093/stcltm/szad064
• Juul SE, Wood TR, German K, et. al. "Predicting 2-year neurodevelopmental outcomes in extremely preterm infants using graphical network and machine learning approaches." EClinicalMedicine, 56(), (2022) 101782. doi: 10.1016/j.eclinm.2022.101782
• Hingorani S, Schmicker R, Ahmad KA, et. al. "Prevalence and Risk Factors for Kidney Disease and Elevated BP in 2-Year-Old Children Born Extremely Premature." Clinical journal of the American Society of Nephrology : CJASN, 17(8), (2022) 1129-1138. doi: 10.2215/CJN.15011121
• Garcia MR, Comstock BA, Patel RM, et. al. "Iron supplementation and the risk of bronchopulmonary dysplasia in extremely low gestational age newborns." Pediatric research, 93(3), (2023) 701-707. doi: 10.1038/s41390-022-02160-2
• Vinukonda G, La Gamma EF. "Emerging therapies for brain recovery after IVH in neonates: Cord blood derived Mesenchymal Stem Cells (MSC) and Unrestricted Somatic Stem Cells (USSC)." Seminars in perinatology, 46(5), (2022) 151598. doi: 10.1016/j.semperi.2022.151598
• Puia-Dumitrescu M, Wood TR, Comstock BA, et. al. "Dexamethasone, Prednisolone, and Methylprednisolone Use and 2-Year Neurodevelopmental Outcomes in Extremely Preterm Infants." JAMA network open, 5(3), (2022) e221947. doi: 10.1001/jamanetworkopen.2022.1947

View All Publications